US Patent 7569566 Inhibitors of tyrosine kinases
Patent 7569566 was granted and assigned to Novartis on August, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 7 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 26 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Pascal Furet0
Paul W Manley0
Sandra Jacob0
Werner Breitenstein0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+60 characters)
Article
Patent abstract
The invention relates to compounds of formula
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07569566 Inhibitors of tyrosine kinases US Patent 7569566 Inhibitors of tyrosine kinases
Infobox
Patent Number
07569566
Patent Number
7569566
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07569566 Inhibitors of tyrosine kinases
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07569566
Date of patent
August 4, 2009
Patent application number
12061334
Date Filed
April 2, 2008
Patent primary examiner
Find more entities like US Patent 7569566 Inhibitors of tyrosine kinases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
